Publications
- Long-term outcomes of ixekizumab treatment in patients with axial spondyloarthritis2023 | First Faculty of Medicine
- Plasma heat shock protein 90 levels in patients with spondyloarthritis and their relation to structural changes: a cross-sectional study2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Elevated Tenascin-C Serum Levels in Patients With Axial Spondyloarthritis2020 | First Faculty of Medicine
- S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity2020 | First Faculty of Medicine
- Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study2019 | First Faculty of Medicine
- Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort2019 | First Faculty of Medicine
- Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis2019 | First Faculty of Medicine
- Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis2019 | First Faculty of Medicine
- Imaging techniques for diagnostic and estimation of axial spondyloarthritis progression2019 | First Faculty of Medicine
- Golimumab in treatment of axial spondyloarthritis - long-term results of treatment2019 | First Faculty of Medicine
Loading network view...
